Status:
COMPLETED
Comparison of TIVA by Closed Loop Anaesthesia Delivery System Versus Target Controlled Infusion Device
Lead Sponsor:
Sir Ganga Ram Hospital
Conditions:
Anesthesia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Total intravenous anaesthesia (TIVA) is now being adopted as a preferred technique for providing GA because of its various inherent advantages like reduced PONV incidence, improved quality of recovery...
Detailed Description
Inhalation anaesthetic were backbone of general anaesthesia (GA) practice till the time an intravenous anaesthetic, propofol was introduced in early 1970's and its commercial availability in 1980's, w...
Eligibility Criteria
Inclusion
- aged 18-65 years
- ASA physical status I-II
- undergoing elective non-cardiac surgery of minimum 60-minutes duration
Exclusion
- Uncompensated cardiovascular disease (e.g. uncontrolled hypertension, atrio-ventricular block, sinus bradycardia, congenital heart disease, reduced LV compliance, diastolic dysfunction)
- Hepato-renal insufficiency
- Uncontrolled endocrinology disease (e.g. diabetes mellitus, hypothyroidism)
- Known allergy/hypersensitivity to the study drug
- Drug dependence/substance abuse
- Requirement of postoperative ventilation
- Refusal to informed consent
Key Trial Info
Start Date :
February 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 17 2025
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04731480
Start Date
February 2 2021
End Date
June 17 2025
Last Update
August 14 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nitin Sethi
New Delhi, National Capital Territory of Delhi, India, 110060
2
Sir Ganga Ram Hospital
New Delhi, National Capital Territory of Delhi, India, 110060